HOME » CONTACT

For questions, pricing, and more information, please contact Meridian Medical Technologies™, Inc.

Homeland Security & EMS

E-mail: MeridianInfo@kingpharm.com and
MeridianService@kingpharm.com
Phone: 443.259.7800 / 800.638.8093
Fax: 443.259.7801

Bryan Salapong
Account Representative
Northern USA

Sean Cowherd
Account Representative
Southern USA

International

E-mail: government@meridianmt.com
Phone: +1.443.259.7800
Fax: +1.443.259.7801

Geoffrey Ritson
Manager, International Sales
UK

Paul Lippner
Director, International Sales

To report an adverse drug event, please contact:

Drug Safety & Pharmacovigilance
Phone:  800.546.4905
Fax:       423.990.0519
E-mail:   DSP@kingpharm.com


Meridian is committed to improving and protecting the quality of life through an active program of business development and considers compelling strategic opportunities. If you are interested in presenting a business development proposal to Meridian Medical Technologies™, Inc. please send or e-mail your expression of interest in writing to:

Ted Marcuccio
Vice President, Business Development & Strategic Planning

Corporate Offices

MERIDIAN MEDICAL TECHNOLOGIES™, INC.
A wholly owned subsidiary of King Pharmaceuticals®, Inc.
Phone: 800.638.8093 or 443.259.7800
Fax: 443.259.7801
Homeland Security & EMS E-mail: MeridianInfo@kingpharm.com
Military and International E-mail: government@meridianmt.com   


KING PHARMACEUTICALS®, INC.
501 Fifth Street
Bristol, Tennessee 37620
Phone:  800.776.3637
http://www.kingpharm.com


IMPORTANT SAFETY INFORMATION: Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments including masks designed specifically for this use. Individuals should not rely solely upon antidotes such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Seek immediate medical attention after injection with antidotes.

PN MMT3705 © 2007 Meridian Medical Technologies™, Inc. a subsidiary of King Pharmaceuticals®, Inc.